| Literature DB >> 29105030 |
Sairah R Khan1, Mubarik Arshad2, Kathryn Wallitt2, Victoria Stewart2, Nishat Bharwani3,4, Tara D Barwick2,4.
Abstract
Magnetic resonance imaging (MRI) is the optimal modality for local staging of gynecological tumors. Advances in functional MRI with diffusion-weighted and dynamic contrast-enhanced sequences provide more detailed information regarding tumor cellularity, vascularity, and viability. Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) now has an established role in imaging for gynecological cancers, particularly staging of locally advanced cervical cancers and pre-salvage exenterative therapy in relapsed gynecologic tumors. Novel PET tracers, targeting other aspects of tumor biology, are being evaluated although none are currently in routine clinical use. New PET/MR scanners have the potential to combine the strengths of both modalities in one sitting. This review covers advances in gynecologic imaging concentrating on cervical, endometrial, and ovarian cancers.Entities:
Keywords: Diffusion-weighted imaging (DWI); Dynamic contrast enhanced MRI (DCE-MRI); Functional imaging; Magnetic resonance imaging (MRI); PET/MR; Positron emission tomography/computed tomography (PET/CT)
Mesh：
Substances：
Year: 2017 PMID： 29105030 DOI： 10.1007/s11912-017-0640-3
Source DB: PubMed Journal: Curr Oncol Rep ISSN： 1523-3790 Impact factor: 5.075